Article
A Novel LC-MS/MS-Based Method for the Diagnosis of ADA2 Deficiency from Dried Plasma Spot.
Molecules (Basel, Switzerland) - 21 Sept 2021
Cafaro Alessia, Pigliasco Federica, Barco Sebastiano, Penco Federica, Schena Francesca, Caorsi Roberta, Volpi Stefano, Tripodi Gino, Gattorno Marco, Cangemi Giuliana
Abstract excerpt
Adenosine Deaminase 2 Deficiency (DADA2) (OMIM: 607575) is a monogenic, autoinflammatory disease caused by the loss of functional homozygous or heterozygous mutations in the ADA 2 gene (previously CECR1, Cat Eye Syndrome Chromosome Region 1). A timely diagnosis is crucial to start Anti-TNF therapies that are efficacious in controlling the disease. The confirmation of DADA2 is based on DNA sequencing and enzymatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
